Les Meilleurs doctors pour le traitement de lymphome de Burkitt en Israël - TOP-20 des médecins

Le Dr Ram Ron traite le lymphome de Burkitt au centre médical Sourasky (Ichilov), l'un des hôpitaux les plus grands et les plus avancés d'Israël.

• Plus de 25 ans d'expérience en oncologie médicale
• Titulaire d'une bourse d'un centre international de premier plan pour la médecine de la reproduction
• Traiter avec une gamme de procédures comprenant l'insémination intra-utérine
• Formé à l'Université de Mysore en Inde

A réalisé plusieurs centaines de greffes de cellules souches – un traitement clé pour les lymphomes agressifs. Le Dr Ram est un hématologue-oncologue triplement certifié, exerçant à l'hôpital Ichilov.

• Plus de 30 articles publiés et un chapitre de manuel sur les cancers du sang
• Formation spécialisée au New York Medical College en hématologie et oncologie
• Détient des certifications en médecine interne, en hématologie et en oncologie médicale

Chef de l'onco-hématologie pédiatrique à l'hôpital pour enfants Dana Dwek – Le Dr El Hasid est spécialisé dans les greffes de moelle osseuse et de sang de cordon chez l'enfant.

• Réaliser plus de 300 procédures de transplantation
• Publier plus de 50 articles de recherche en oncologie pédiatrique
• Être membre de l'American Association for Hematology
• Se former au City of Hope Hospital de Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Le Dr Michael Shapira se spécialise en transplantation de moelle osseuse au centre médical Sourasky (Ichilov), avec une vaste expérience dans le traitement des cancers du sang.

• Diplômé de la faculté de médecine de l'Université hébraïque
• Spécialisé en médecine interne au centre médical Hadassah
• Médecin principal en transplantation de moelle osseuse à Hadassah

Le Dr Fredi Aviv possède plus de 30 ans d'expérience dans le traitement des cancers du sang au principal centre médical Sourasky de Tel Aviv.

• 31 ans dédiés à l'onco-hématologie
• Spécialisation dans les cancers du sang agressifs
• Pratique au célèbre centre médical Sourasky
• Expertise dans les dernières thérapies médicales et biologiques

Le Dr Dror Levin est spécialisé en hématologie-oncologie pédiatrique, se concentrant sur le lymphome de Burkitt au centre médical Sourasky de Tel Aviv.

• Directeur du département d'hématologie-oncologie pédiatrique au centre médical Sourasky
• Spécialisé en hématologie et oncologie pédiatriques au centre médical pour enfants Schneider
• Membre de la Société israélienne d'hématologie et d'oncologie pédiatriques (ISPHO)
• Étudier l'oncologie des os et des tissus mous à l'Institut orthopédique Rizzoli en Italie

Expert de premier plan en hématologie reconnu par l'American Society of Hematology, le Dr Yair traite des patients au centre médical Sourasky de Tel Aviv.

• Effectuer une résidence spécialisée en hématologie au centre médical de Tel Aviv
• Être lauréat de plusieurs subventions de recherche et de prix pour l'excellence clinique
• Être membre actif des associations israélienne et américaine d'hématologie
• Se concentrer sur la recherche sur la leucémie, y compris les formes lymphocytaires

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Spécialisé en onco-hématologie, traite les cancers du sang et du système lymphatique au centre médical Assuta.

• Se concentrer exclusivement sur les hémopathies malignes comme le lymphome de Burkitt
• Fournir un diagnostic expert et une planification de traitement pour les cancers du sang complexes
• Travailler au sein du célèbre réseau hospitalier israélien Assuta

Plus de 3 500 greffes de moelle osseuse réalisées – le Dr Stepensky est reconnu par Forbes comme l'un des meilleurs médecins.

• 20 ans de pratique spécialisée en hématologie pédiatrique
• Expert dans le traitement des enfants atteints de cancers du sang rares comme le lymphome de Burkitt
• Exerce au centre médical Hadassah en Israël
• Reconnu pour son haut niveau d'expertise et ses soins compatissants

Le professeur Zila Zuckerman est une spécialiste en hématologie et transplantologie, spécialisée dans les cancers du sang au centre médical Rambam.

• Sous-spécialiste en transplantologie pour les troubles sanguins
• Professeure académique avec une expertise en recherche
• Exerce dans un centre médical national de premier plan

Spécialisé dans le traitement des lymphomes au centre médical Rambam.

• Se concentrer sur l'hématologie avec une vaste expérience des cas de lymphome
• Travailler dans un centre médical de premier plan reconnu pour les soins oncologiques
• Se consacrer à l'élaboration de plans de traitement personnalisés pour les patients

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.